Search

Search Results
Results 6621 - 6630 of 8493 for Skin Cancer
  • Scemblix
    Drug - 4 Sep 2025
    Consumer Medicine Information (CMI) about Scemblix intended for persons living in Australia.
  • Nanostructures boost CRISPR delivery for genetic medicine
    News - 2 Sep 2025
    With the power to rewrite the genetic code underlying countless diseases, CRISPR holds immense promise to revolutionize medicine. But until scientists can deliver its gene-editing machinery safely and...
  • Using AI to enhance the design of nanoparticles for RNA therapies
    News - 18 Aug 2025
    Using artificial intelligence, MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies.
  • Blincyto
    Drug - 12 Aug 2025
    Consumer Medicine Information (CMI) about Blincyto intended for persons living in Australia.
  • Spironolactone Viatris
    Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Spironolactone Viatris intended for persons living in Australia.
  • Spiractin
    Drug - 31 Jul 2025
    Consumer Medicine Information (CMI) about Spiractin intended for persons living in Australia.
  • New RNA therapy reverses symptoms of progeria in mouse models
    News - 29 Jul 2025
    Children who develop deep wrinkles, stunted growth, and rapidly aging bones and blood vessels as early as 1 to 2 years of age may be suffering from Hutchinson-Gilford Progeria Syndrome (HGPS), a rare...
  • Solu-Cortef
    Drug - 22 Jul 2025
    Consumer Medicine Information (CMI) about Solu-Cortef intended for persons living in Australia.
  • Immune cells navigate tissues with coordinated cytoskeletal forces
    News - 21 Jul 2025
    Immune responses rely on the efficient movement of immune cells within the complex and geometrically unpredictable three-dimensional tissues that make up our bodies.
  • Weekly injectable drug offers hope for Parkinson's patients
    News - 11 Jul 2025
    A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback